PEREGRINE PHARMACEUTICALS INC (PPHM) has 36 open-market insider trades by 7 insiders since 2006. The most active filer is Eric S. Swartz, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Eric S. Swartz | Dir | — | 22 | $571K | 2012-03-14 |
| Mark R. Bamforth | Dir | — | 2 | $397K | 2017-10-27 |
| Carlton M. Johnson | Dir | — | 3 | $26K | 2007-08-31 |
| Paul J. Lytle | CFO | — | 3 | $25K | 2017-04-28 |
| F. David King | V.P.Business Development | — | 2 | $23K | 2007-08-24 |
| Steven W. King | Pres | — | 3 | $20K | 2017-10-31 |
| Thomas A. Waltz | Dir | — | 1 | $3K | 2006-12-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark R. Bamforth | Director | Buy | $235K | 2017-10-27 |
| Mark R. Bamforth | Director | Buy | $162K | 2017-10-27 |
| Eric S. Swartz | Director | Buy | $10K | 2012-03-14 |
| Eric S. Swartz | Director | Buy | $16K | 2010-11-08 |
| Paul J. Lytle | CFO | Buy | $9K | 2010-09-24 |
| Paul J. Lytle | CFO | Buy | $7K | 2010-09-23 |
| Eric S. Swartz | Director | Buy | $14K | 2010-02-18 |
| Eric S. Swartz | Director | Buy | $58K | 2010-02-17 |
| Eric S. Swartz | Director | Buy | $55K | 2010-02-05 |
| Eric S. Swartz | Director | Buy | $64K | 2010-01-15 |
| Eric S. Swartz | Director | Buy | $62K | 2010-01-08 |
| Eric S. Swartz | Director | Buy | $59K | 2010-01-07 |
| Eric S. Swartz | Director | Buy | $14K | 2008-01-14 |
| Carlton M. Johnson | Director | Buy | $9K | 2007-08-31 |
| Eric S. Swartz | Director | Buy | $14K | 2007-08-31 |